Search

everythinglearnresearchcommunity

for

Search:↓

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Finasteride didn't significantly improve ICPPS symptoms, more research needed.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Using finasteride with TIP extends time off period for prostate cancer patients.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Finasteride 1-mg doesn't harm sperm or pregnancy chances.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Oral finasteride works better than topical minoxidil for hair growth, both are safe.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Suppressing certain hormones might help prevent prostate cancer.

More adolescent girls in urban areas of India have Polycystic Ovary Syndrome compared to those in rural areas.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

Finasteride effectively treats mild to moderate hair loss in men aged 18-41, with some side effects.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Finasteride effectively treats baldness but may cause sexual side effects.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.